Meso Numismatics, Inc. Files 2023 Annual Report (10-K)
Ticker: RMTG · Form: 10-K · Filed: Apr 15, 2024 · CIK: 1760026
| Field | Detail |
|---|---|
| Company | Meso Numismatics, Inc. (RMTG) |
| Form Type | 10-K |
| Filed Date | Apr 15, 2024 |
| Risk Level | low |
| Pages | 15 |
| Reading Time | 17 min |
| Key Dollar Amounts | $0.001, $6,341, $11,725 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, Annual Report, Meso Numismatics, SEC Filing, Financials
TL;DR
<b>Meso Numismatics, Inc. has filed its 2023 annual report on Form 10-K, detailing its financial performance and corporate information.</b>
AI Summary
MESO NUMISMATICS, INC. (RMTG) filed a Annual Report (10-K) with the SEC on April 15, 2024. Meso Numismatics, Inc. filed its annual report on Form 10-K for the fiscal year ended December 31, 2023. The company is registered in Nevada and its principal executive offices are located in Boca Raton, Florida. Meso Numismatics, Inc. is classified under SIC code 5990 (Retail-Retail Stores, NEC). The company's common stock, par value $0.001 per share, is registered under Section 12(g) of the Exchange Act. The filing indicates that Meso Numismatics, Inc. is not a well-known seasoned issuer and is a smaller reporting company.
Why It Matters
For investors and stakeholders tracking MESO NUMISMATICS, INC., this filing contains several important signals. This 10-K filing provides a comprehensive overview of Meso Numismatics, Inc.'s operations and financial standing for the fiscal year 2023, which is crucial for investors to assess the company's performance and future prospects. As a smaller reporting company, this filing offers insights into a less-covered entity, potentially revealing investment opportunities or risks for those interested in niche markets.
Risk Assessment
Risk Level: low — MESO NUMISMATICS, INC. shows low risk based on this filing. The risk is low as this is a standard annual report filing (10-K) which is a routine disclosure for public companies, and no immediate negative financial indicators are present in the header information.
Analyst Insight
Investors should review the full 10-K filing to understand Meso Numismatics, Inc.'s financial health, business strategy, and any disclosed risks.
Key Numbers
- 2023 — Fiscal Year End (Annual Report period)
- December 31 — Fiscal Year End Date (Annual Report period)
- 000-56010 — Commission File Number (SEC Filing identifier)
- 5990 — SIC Code (Industry classification)
- $0.001 — Par Value (Common Stock par value)
Key Players & Entities
- MESO NUMISMATICS, INC. (company) — Filer name
- 2023 (date) — Fiscal year end
- December 31, 2023 (date) — Fiscal year end
- Boca Raton, Florida (location) — Principal executive offices
- 5990 (industry_code) — Standard Industrial Classification
- 000-56010 (filing_id) — Commission file number
- Nevada (jurisdiction) — State of incorporation
- Common Stock (security) — Registered security
FAQ
When did MESO NUMISMATICS, INC. file this 10-K?
MESO NUMISMATICS, INC. filed this Annual Report (10-K) with the SEC on April 15, 2024.
What is a 10-K filing?
A 10-K is a comprehensive annual financial report required by the SEC, covering audited financials, business operations, risk factors, and management discussion. This particular 10-K was filed by MESO NUMISMATICS, INC. (RMTG).
Where can I read the original 10-K filing from MESO NUMISMATICS, INC.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by MESO NUMISMATICS, INC..
What are the key takeaways from MESO NUMISMATICS, INC.'s 10-K?
MESO NUMISMATICS, INC. filed this 10-K on April 15, 2024. Key takeaways: Meso Numismatics, Inc. filed its annual report on Form 10-K for the fiscal year ended December 31, 2023.. The company is registered in Nevada and its principal executive offices are located in Boca Raton, Florida.. Meso Numismatics, Inc. is classified under SIC code 5990 (Retail-Retail Stores, NEC)..
Is MESO NUMISMATICS, INC. a risky investment based on this filing?
Based on this 10-K, MESO NUMISMATICS, INC. presents a relatively low-risk profile. The risk is low as this is a standard annual report filing (10-K) which is a routine disclosure for public companies, and no immediate negative financial indicators are present in the header information.
What should investors do after reading MESO NUMISMATICS, INC.'s 10-K?
Investors should review the full 10-K filing to understand Meso Numismatics, Inc.'s financial health, business strategy, and any disclosed risks. The overall sentiment from this filing is neutral.
How does MESO NUMISMATICS, INC. compare to its industry peers?
Meso Numismatics, Inc. operates in the retail sector, specifically under the 'Retail Stores, NEC' classification, suggesting a focus on specialized retail goods.
Are there regulatory concerns for MESO NUMISMATICS, INC.?
The company is subject to the reporting requirements of the Securities Exchange Act of 1934, including the filing of annual reports (10-K).
Industry Context
Meso Numismatics, Inc. operates in the retail sector, specifically under the 'Retail Stores, NEC' classification, suggesting a focus on specialized retail goods.
Regulatory Implications
The company is subject to the reporting requirements of the Securities Exchange Act of 1934, including the filing of annual reports (10-K).
What Investors Should Do
- Analyze the full 10-K for detailed financial statements and management discussion.
- Research the company's business model and market position within the retail sector.
- Monitor future filings for updates on performance and strategic initiatives.
Key Dates
- 2024-04-15: 10-K Filing — Filing of the annual report for the fiscal year ended December 31, 2023.
Year-Over-Year Comparison
This is the initial 10-K filing for the fiscal year ended December 31, 2023, as indicated by the absence of a transition report and the standard annual report format.
Filing Stats: 4,373 words · 17 min read · ~15 pages · Grade level 14.8 · Accepted 2024-04-15 16:32:54
Key Financial Figures
- $0.001 — e Exchange Act: Common Stock, par value $0.001 per share Indicate by check mark if t
- $6,341 — ,863 square feet with a monthly rent of $6,341 and a security deposit of $11,725. GS
- $11,725 — ent of $6,341 and a security deposit of $11,725. GSCG's manufacturing facility in Can
Filing Documents
- ea0203857-10k_meso.htm (10-K) — 1143KB
- ea020385701ex3-8_meso.htm (EX-3.8) — 2KB
- ea020385701ex3-9_meso.htm (EX-3.9) — 2KB
- ea020385701ex31-1_meso.htm (EX-31.1) — 14KB
- ea020385701ex31-2_meso.htm (EX-31.2) — 14KB
- ea020385701ex32-1_meso.htm (EX-32.1) — 8KB
- image_001.jpg (GRAPHIC) — 3KB
- ex3-8_001.jpg (GRAPHIC) — 2010KB
- ex3-8_002.jpg (GRAPHIC) — 316KB
- ex3-9_001.jpg (GRAPHIC) — 745KB
- ex3-9_002.jpg (GRAPHIC) — 114KB
- 0001213900-24-032991.txt ( ) — 10763KB
- mssv-20231231.xsd (EX-101.SCH) — 62KB
- mssv-20231231_cal.xml (EX-101.CAL) — 36KB
- mssv-20231231_def.xml (EX-101.DEF) — 324KB
- mssv-20231231_lab.xml (EX-101.LAB) — 519KB
- mssv-20231231_pre.xml (EX-101.PRE) — 318KB
- ea0203857-10k_meso_htm.xml (XML) — 574KB
BUSINESS
BUSINESS 1 ITEM 1A.
RISK FACTORS
RISK FACTORS 10 ITEM 1B. UNRESOLVED STAFF COMMENTS 21 ITEM 1C. CYBERSECURITY 21 ITEM 2.
PROPERTIES
PROPERTIES 21 ITEM 3.
LEGAL PROCEEDINGS
LEGAL PROCEEDINGS 21 ITEM 4. MINE SAFETY DISCLOSURES 21 PART II 22 ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 22 ITEM 6. [RESERVED] 23 ITEM 7.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 24 ITEM 7A.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 30 ITEM 8.
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA 30 ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE 30 ITEM 9A.
CONTROLS AND PROCEDURES
CONTROLS AND PROCEDURES 30 ITEM 9B. OTHER INFORMATION 31 ITEM 9C Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 31 PART III 32 ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 32 ITEM 11.
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 34 ITEM 12.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS 35 ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE 36 ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES 36 PART IV ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES 37 ITEM 16. 10-K SUMMARY 38
SIGNATURES
SIGNATURES 39 i As used in this Annual Report on Form 10-K, unless the context otherwise requires, the terms the "Company," "Registrant," "we," "us," "our," "Meso," or "MSSV" refer to Meso Numismatics, Inc., a Nevada corporation. FORWARD-LOOKING Except for statements of historical fact, some information in this document contains "forward-looking statements" that involve substantial risks and uncertainties. You can identify these forward-looking statements by words such as "may," "will," "should," "anticipate," "estimate," "plans," "potential," "projects," "continuing," "ongoing," "expects," "management believes," "we believe," "we intend" or the negative of these words or other variations on these words or comparable terminology. The statements that contain these or similar words should be read carefully because these statements discuss our future expectations, contain projections of our future results of operations or of our financial position, or state other forward-looking information. We believe that it is important to communicate our future expectations to our investors. However, there may be events in the future that we are not able accurately to predict or control. Further, we urge you to be cautious of the forward-looking statements which are contained in this registration statement because they involve risks, uncertainties and other factors affecting our operations, market growth, service, products and licenses. The factors listed in the sections captioned "Risk Factors" and "Description of Business," as well as other cautionary language in this registration statement and events in the future may cause our actual results and achievements, whether expressed or implied, to differ materially from the expectations we describe in our forward-looking statements. We operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for us to predict all of those risks, nor can we assess the imp
BUSINESS
ITEM 1. BUSINESS Overview Since the acquisition of Global Stem Cell Group in August of 2021, our focus has been mainly dedicated to its operations serving the markets in the regenerative medicine industry. We believe stem cell therapy is becoming an increasingly effective clinical solution for treating conditions that traditional or conventional medicine only offers within palliative care and pain management. Patients around the world are seeking a natural regenerative alternative without the potential risks and side effects sometimes associated with conventional pharmaceuticals. We work with doctors and their staff to provide products, solutions, equipment, services, and training to help them be successful in the application of Stem Cell Therapies. Our team combines solutions from extensive clinical research with the manufacturing and commercialization of viable cell therapy and immune support related products that we believe will change the course of traditional medicine around the world forever. Our strategy allows us the ability to create immediate revenue streams through product sales, distribution, and clinical applications, driven by our extensive education platform. Our revenue comes directly from the training and the seminars, from the resale of these kits, products, and equipment, services, and from the reoccurring application of our process using the kits and solutions we provide. Global Stem Cells Group is a leader in the Stem Cell and Regenerative Medicine fields, covering clinical research, patient applications, along with physician training through our state-of-the-art global network of companies. The Company's mission is to enable physicians to make the benefits of stem cell medicine a reality for patients around the world. They have been educating doctors on the science and application of cell-based therapeutics for the past 10 years. Our professional trademarked association "ISCCA" INTERNATIONAL SOCIETY FOR STEM CELL APPLICATION is a global